Funding Received
$54.8 Million in 5 Rounds from 2 Investors
Most Recent Funding
$750 Thousand Debt Financing on October 26, 2010
Headquarters:
Burlingame, CA
Description:
Juvaris BioTherapeutics develops adjuvanted vaccines and immunotherapeutics to treat cancer and infectious diseases.
Categories:
Biotechnology
Website:
http://www.juvaris.com

Company Details

Update

Juvaris BioTherapeutics, Inc. is developing adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer.

The Company's platform technology induces profound immunostimulation via cationic lipid-DNA (non-coding) complexes (CLDC). The Company's lead product candidate, JVRS-100, stimulates adaptive and innate immune responses at levels many fold higher than other drugs in its class. JVRS-100 is in clinical development as a vaccine adjuvant and an immunotherapeutic.

Funding Rounds (5) - $750k

Update

Investors (2)

Update

Offices/Locations (1)

Update
  • Office

    866 Malcolm Road

    Suite 100

    Burlingame, CA 94010

    USA

Images (1)

Update
  • Dcb961c19bceb0c5731f7f888b2c3fab